Gefitinib
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9404 publications
Machine learning prognostic model and drug survival analysis for lung adenocarcinoma in the context of radiotherapy.
Journal: Pakistan journal of pharmaceutical sciences
Published: September 08, 2026
Co-Occurring EGFR L858R Mutation and HER2 Amplification in NSCLC Identified by Stepwise Molecular Profiling.
Journal: The American journal of case reports
Published: September 02, 2026
DRESS during chemotherapy with carboplatin, pemetrexed, and osimertinib for lung adenocarcinoma: A case report.
Journal: Internal medicine (Tokyo, Japan)
Published: August 10, 2026
Retraction: The long non-coding RNA SNHG5 regulates gefitinib resistance in lung adenocarcinoma cells by targetting miR-377/CASP1 axis.
Journal: Bioscience reports
Published: July 30, 2026
Allosteric co-binding restores tyrosine kinase inhibitor affinity in T790M-mutant EGFR through conformational reprogramming.
Journal: Journal of biomolecular structure & dynamics
Published: July 29, 2026
Attenuation of EGFR-Mediated Cellular Signaling by Sialidase-Mediated Desialylation.
Journal: Research square
Published: July 10, 2026
Drug-induced paronychia: a disproportionality and time-to-onset pharmacovigilance study using FAERS and JADER.
Journal: Cutaneous and ocular toxicology
Published: July 07, 2026
Simultaneous determination of bosutinib and its metabolite in rat plasma by UPLC-MS/MS: Development, validation and application to pharmacokinetic and metabolic stability studies.
Journal: Chemico-biological interactions
Published: June 28, 2026
Antineoplastic Activity of the Combination Loratadine-Simvastatin-Gefitinib in HPV-Positive Cervical Cancer Cells: In Vitro and In Vivo Studies.
Journal: Cancers
Published: June 27, 2026
Corrigendum to "Marsdenia tenacissima extract potentiates the anti-lung cancer efficacy of gefitinib through dual regulation of the Wnt pathway and ferroptosis" [J. Ethnopharmacol. 359 (2026) 121121].
Journal: Journal of ethnopharmacology
Published: June 23, 2026
Maximizing Lipidome Coverage of Mouse Liver Following the IV Administration of Gefitinib by Combining Both UHPLC-MS-Based Untargeted and Targeted Lipidomics.
Journal: Journal of proteome research
Published: June 13, 2026
Last Updated: 09/26/2026